Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.3299
Delayed Data
As of May 04
 +0.0109 / +3.42%
Today’s Change
0.21
Today|||52-Week Range
0.60
-21.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization30.0K37.0K38.0K41.0K
 
 
 
 
 
 
Operating ExpensesGross Income-30.0K-37.0K-38.0K-41.0K
 
 
 
 
 
General Expenses9.6M10.1M9.8M9.7M
 
 
 
 
 
Research And Development6.0M7.7M7.3M7.2M
 
 
 
 
 
Total Operating Expenses9.7M10.2M9.8M9.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.7M-10.2M-9.8M-9.7M
 
 
 
 
 
Interest Expense On Debt0.001.0K101.0K501.0K
 
 
 
 
Other Expenses4.0K-1.0K-15.0K16.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.6M-10.2M-9.9M-10.2M
 
 
 
 
 
Net Income-9.6M-10.2M-9.9M-10.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS159.5M162.1M163.6M163.6M
 
 
 
 
 
Shares To Calculate EPS Diluted159.5M162.1M163.6M163.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.06-$0.06-$0.06
 
 
 
 
 
EPS Diluted-$0.06-$0.06-$0.06-$0.06